Tag Archives: Accelerator

NIH Selects Biopharmas Lead Asset for Commercialization Accelerator Program

A Maxim Group analyst reported on news and upcoming catalysts for this late-stage drug developer. In a Sept. 13 research note, Maxim Group analyst James McCarthy reported the National Institutes of Health (NIH) chose Soligenix Inc.’s (SNGX:NASDAQ) lead candidate SGX942 (dusquetide) for oral mucositis in head-and-neck cancer for its Small Business Innovation Research/Small Business Technology Transfer Commercialization Accelerator Program (CAP) ...

Read More »

NIH Selects Biopharmas Lead Asset for Commercialization Accelerator Program

A Maxim Group analyst reported on news and upcoming catalysts for this late-stage drug developer. In a Sept. 13 research note, Maxim Group analyst James McCarthy reported the National Institutes of Health (NIH) chose Soligenix Inc.’s (SNGX:NASDAQ) lead candidate SGX942 (dusquetide) for oral mucositis in head-and-neck cancer for its Small Business Innovation Research/Small Business Technology Transfer Commercialization Accelerator Program (CAP) ...

Read More »